Trial Search Results

Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI

The goal of the project is to evaluate osteonecrosis before and after decompression surgery with ferumoxytol-enhanced MRI.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Drug: Ferumoxytol-enhanced magnetic resonance imaging
  • Device: Magentic Resonance Imaging

Phase:

Phase 4

Eligibility


Inclusion Criteria:

   - Osteonecrosis

   - planned decompression surgery with autologous stem cell transplant

Exclusion Criteria:

   - Contraindications for magnetic resonance imaging

   - Hemosiderosis/hemochromatosis ( patients can still be included in the non-ferumoxytol
   arm)

Ages Eligible for Study

8 Years - 40 Years

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Anne Sawyer
650-302-2846
Recruiting